Compare GNTA & CFND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | GNTA | CFND |
|---|---|---|
| Founded | 2014 | N/A |
| Country | Italy | |
| Employees | 13 | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 19.9M | 23.8M |
| IPO Year | N/A | 2025 |
| Metric | GNTA | CFND |
|---|---|---|
| Price | $1.84 | $3.03 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 1.5M | 32.8K |
| Earning Date | 03-24-2026 | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.55 | $2.85 |
| 52 Week High | $10.00 | $9.67 |
| Indicator | GNTA | CFND |
|---|---|---|
| Relative Strength Index (RSI) | 59.70 | 39.15 |
| Support Level | $1.31 | $2.85 |
| Resistance Level | $2.12 | $4.14 |
| Average True Range (ATR) | 0.19 | 0.21 |
| MACD | -0.04 | -0.02 |
| Stochastic Oscillator | 72.46 | 21.54 |
Genenta Science SPA is a clinical-stage biotechnology company engaged in the development of hematopoietic stem cell gene therapies for the treatment of solid tumors and cancer. The company's products include Temferon - a product to treat glioblastoma multiforme, a solid tumor affecting the brain.
C1 Fund Inc is a non-diversified, closed-end management investment company designed to give investors access to the private digital asset ecosystem. Its investment objective is to maximize its portfolio's total return. The fund targets a handpicked portfolio of the late-stage private companies driving the future of digital asset services and technology. It offers early access to the next generation of category-defining companies and aims to bridge the gap between public and private markets and give investors access to the private companies with the safeguards of a NYSE listed fund that is regulated and liquid.